The clinical course of inflammatory bowel disease and the impact of th
erapies on the disease process have traditionally been assessed using
composite activity indices. These indices are variably composed of sub
jective symptoms, endoscopic appearance, histology of mucosal biopsy s
pecimens, and blood, urine, or tissue levels of acute-phase reactants
or soluble mediators of inflammation. More recently, health-related qu
ality of life (HRQOL, also called functional status), a subjective mea
surement of physical, emotional, and social function and perception ha
s become a key element in the assessment of health status in inflammat
ory bowel disease. Both disease activity and functional status may cha
nge with time and specific treatment depending on disease-related feat
ures. HRQOL, however, is also affected by disease-independent features
. Each index assessing disease activity or HRQOL should be tailored to
the study population (eg Crohn's disease, ulcerative colitis, pouchit
is, pediatric patients) and research questions of the study. To adequa
tely gauge disease severity and health status, both cross-sectional an
d prospective studies are critical.